🎗️ OncologyTablet
Itovebi
Inavolisib
PI3K-alpha inhibitor for HR-positive, HER2-negative breast cancer with PIK3CA mutation.
Form
Tablet
Uses
1
Side effects
6
Category
Oncology
01
What is Itovebi used for?
- HR+/HER2- advanced breast cancer with PIK3CA mutation
02
Inavolisib side effects
Common side effects of Inavolisib include:
Hyperglycemia
Stomatitis
Diarrhea
Rash
Nausea
Fatigue
CommonModerateLess common
03
Inavolisib warnings & precautions
- Hyperglycemia management required. Monitor blood glucose
- Embryo-fetal toxicity
- Severe cutaneous reactions possible
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Itovebi in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.